Watson Pharmaceuticals, Inc. (NYSE:WPI) develops, manufactures, and sells generic and brand name pharmaceutical products. The Company's core focus is specialty products, nephrology, urology, and generic products.
Watson Pharmaceuticals is currently trading 1.1% versus its previous trading session close, and it has calculated support and resistance at $48.20 and $53.75 respectively. Clearly with this action this range has been penetrated, and traders will be reviewing price action to establish a new tradable range
The overall market index S&P 500 is trading higher by 0.36% from its previous trading close, which means that Watson Pharmaceuticals stock is outperforming the overall market.